This report describes the first study to use national data from the Pharmaceutical Benefits Scheme (PBS) to investigate the patterns of asthma medication use in Australia.

This report provides a background to defining and measuring National Health Priority Area indicators for asthma. The issues surrounding the selection, operational definition and measurement of indicators for asthma are presented. The report incorporates the view of stakeholders who were consulted in the development process through workshops around Australia.